EBOLA, THE YEAR 2014 EPIDEMIOLOGICAL AND SOCIAL ASPECTS


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

Ebola disease epidemic, which started suddenly in winter 2014 in Guinea, has spread to several Western African countries by September. About 4 thousand people got sick already, more than two thousands of them died, including more than 140 medical professionals. Governments of Guinea, Sierra Leone and, in particular, Liberia recognize the enormous social and economic damage caused by Ebola, and the inability to stop the spread of infection on their own. The World Health Organization has declared the Ebola epidemic «a Public Health Emergency of International Concern» requiring concerted actions by entire world community. The review provides basic information on the epidemiology, pathogenesis, clinical presentation and treatment of Ebola infection. The epidemic progress in 2014 is considered in detail alongside with social, environmental and epidemiological reasons that led to its unprecedented scale. We discuss also ongoing and planned control anti-epidemic measures, as well as forecasts of the epidemiological situation and the possibility of using «experimental» preventive and therapeutic drugs.

Толық мәтін

Рұқсат жабық

Авторлар туралы

A. PLATONOV

Central Research Institute of Epidemiology

Email: platonov@pcr.ru
Moscow

O. PLATONOVA

Central Research Institute of Epidemiology

Email: oplatonova@pcr.ru
Moscow

V. MALEEV

Central Research Institute of Epidemiology

Email: maleyev@pcr.ru
Moscow

Әдебиет тізімі

  1. World Health Organization. Ebola virus disease. http://www. who.int/csr/disease/ebola/en/
  2. Centers for Disease Control and Prevention. Ebola Hemorrhagic Fever. 2014. http://www.cdc.gov/vhf/ebola/ index.html
  3. European Centre for Disease Prevention and Control. Ebola and Marburg fevers. 2014. http://www.ecdc.europa.eu/en/ healthtopics/ebola_marburg_fevers/Pages/index.aspx
  4. Kuhn J.H., Bao Y., Bavari S. et al. Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA. Arch. Virol. 2014; 159(5): 1229-1237.
  5. Feldmann H., Geisbert T.W. Ebola haemorrhagic fever. Lancet 2011; 377(9768): 849-862.
  6. Del Rio C., Mehta A.K., Lyon G.M. III, Guarner J. Ebola hemorrhagic fever in 2014: The tale of an evolving epidemic. Ann. Intern. Med. 2014 Aug 19. PubMed PMID: 25133433.
  7. Olival K.J., Hayman D.T. Filoviruses in bats: current knowledge and future directions. Viruses 2014; 6(4): 1759- 1788.
  8. Leroy E.M., Kumulungui B., Pourrut X. et al. Fruit bats as reservoirs of Ebola virus. Nature 2005; 438(7068): 575-576.
  9. Bausch D.G., Schwarz L. Outbreak of ebola virus disease in Guinea: where ecology meets economy. PLoS Negl. Trop. Dis. 2014; 8(7): e3056.
  10. Weingartl H.M., Nfon C., Kobinger G. Review of Ebola virus infections in domestic animals. Dev. Biol. (Basel) 2013; 135: 211-218.
  11. Bermejo M., Rodriguez-Teijeiro J.D., Illera G. et al. Ebola outbreak killed 5000 gorillas. Science 2006; 314(5805): 1564.
  12. O’Shea T.J., Cryan P.M., Cunningham A.A. et al. Bat flight and zoonotic viruses. Emerg. Infect. Dis. 2014; 20 (5): 741-745.
  13. Tucker C.J., Wilson J.M., Mahoney R. et al. Climatic and ecological context of the 1994-1996 Ebola outbreaks. Photogrammetric Eng. Remote Sens. 2002; 68(2): 147-152.
  14. Pinzon J.E., Wilson J.M., Tucker C.J. et al. Trigger events: enviroclimatic coupling of Ebola hemorrhagic fever outbreaks. Am. J. Trop. Med. Hyg. 2004; 71(5): 664-674.
  15. Leroy E.M., Epelboin A., Mondonge V. et al. Human Ebola outbreak resulting from direct exposure to fruit bats in Luebo, Democratic Republic of Congo, 2007. Vector Borne Zoonotic Dis. 2009; 9(6): 723-728.
  16. Becquart P., Wauquier N., Mahlakoiv T. et al. High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon. PLoS One 2010; 5(2): e9126.
  17. Борисевич И.В., Маркин В.А., Фирсова И.В., Евсеев А.А., Хамитов Р.А., Максимов В.А. Эпидемиология, профилактика, клиника и лечение геморрагических лихорадок (Марбург, Эбола, Ласса и Боливийской). Вопр. вирусол. 2006; (5): 8-16.
  18. Титенко А.М., Андаев Е.И. Научно-методологический подход к эпидемиологическому анализу и лабораторной диагностике болезней, вызванных вирусами Марбург и Эбола. Пробл. особо опасных инф. 2012; (3): 38-44.
  19. Baize S., Pannetier D., Oestereich L. et al. Emergence of Zaire Ebola Virus Disease in Guinea - Preliminary Report. N. Engl. J. Med. 2014 Apr 16. PubMed PMID: 24738640.
  20. Акинфеева Л.А., Аксенова О.И., Василевич И.В., Гинько З.И., Зарьков К.А. и др. Случай вирусной геморрагической лихорадки Эбола. Инфекц. бол. 2005; 3(1): 85-88.
  21. World Health Organization. Ebola virus disease. Fact sheet №103. Updated April 2014. http://www.who.int/mediacentre/ factsheets/fs103/en/
  22. Lefebvre A., Fiet C., Belpois-Duchamp C. et al. Case fatality rates of Ebola virus diseases: A meta-analysis of World Health Organization data. Med. Mal. Infect. 2014). http://dx.doi. org/10.1016/j.medmal.2014.08.005
  23. Ng S., Basta N.E., Cowling B.J. Association between temperature, humidity and ebolavirus disease outbreaks in Africa, 1976 to 2014. Euro Surveill. 2014; 19(35): pii=20892.http://www.eurosurveillance.org/ViewArticle. aspx?ArticleId=20892
  24. Tambo E., Ugwu E.C., Ngogang J.Y. Need of surveillance response systems to combat Ebola outbreaks and other emerging infectious diseases in African countries. Infect. Dis. Poverty 2014; 3: 29.
  25. Jezek Z., Szczeniowski M.Y., Muyembe-Tamfum J.J. et al. Ebola between outbreaks: intensified Ebola hemorrhagic fever surveillance in the Democratic Republic of the Congo, 19811985. J. Infect. Dis. 1999; 179(Suppl 1): S60-S64.
  26. MacNeil A., Farnon E.C., Morgan O.W. et al. Filovirus outbreak detection and surveillance: lessons from Bundibugyo. J. Infect. Dis. 2011; 204(Suppl 3): S761-S767.
  27. Richards G.A., Murphy S., Jobson R. et al. Unexpected Ebola virus in a tertiary setting: clinical and epidemiologic aspects. Crit. Care Med. 2000; 28(1): 240-244.
  28. Legrand J., Grais R.F., Boelle PY. et al. Understanding the dynamics of Ebola epidemics. Epidemiol. Infect. 2007; 135(4): 610-621.
  29. Chowell G., Hengartner N.W., Castillo-Chavez C. et al. The basic reproductive number of Ebola and the effects of public health measures: the cases of Congo and Uganda. J. Theor. Biol. 2004; 229(1): 119-126.
  30. Briand S., Bertherat E., Cox P. et al. The International Ebola Emergency. N. Engl. J. Med. 2014 Aug 20. PubMed PMID: 25140855.
  31. Frieden T.R., Damon I., Bell B.P. et al. Ebola 2014 - new challenges, new global response and responsiblity. N. Engl. J. Med. 2014 Aug 20. PubMed PMID: 25140858.
  32. Eichner M., Dowell S.F., Firese N. Incubation period of Ebola hemorrhagic virus subtype Zaire. Osong. Public Health Res. Perspect. 2011; 2(1): 3-7.
  33. Платонов А.Е., Малеев В.В., Карань Л.С., Санникова И.В., Пасечников В.Д., Платонова О.В. и др. Крымская геморрагическая лихорадка в Евразии в XXI веке: клиника и диагностика. Эпидемиол. и инфекц. болезни. Актуал. вопр. 2012; (5): 45-54.
  34. Kortepeter M.G., Bausch D.G., Bray M. Basic clinical and laboratory features of filoviral hemorrhagic fever. J. Infect. Dis. 2011; 204(Suppl 3): 810-816.
  35. Maron D.F. Ebola doctor reveals how infected Americans were cured. Nature News 2014; doi: 10.1038/nature.2014.15791 http://www.nature.com/news/ebola-doctor-reveals-how-infected- americans-were- cured-1.15791
  36. Leroy E.M., Baize S., Volchkov V.E. et al. Human asymptomatic Ebola infection and strong inflammatory response. Lancet 2000; 355(9222): 2210-2215.
  37. Leroy E.M., Baize S., Debre P. et al. Early immune responses accompanying human asymptomatic Ebola infections. Clin. Exp. Immunol. 2001; 124(3): 453-460.
  38. Куличенко А.Н., Малецкая О.В., Василенко Н.Ф., Бейер А.П., Санникова И.В., Пасечников В.Д. и др. Крымская геморрагическая лихорадка в Евразии в XXI веке: эпидемиологические аспекты. Эпидемиол. инфекц. болезни. Актуал. вопр. 2012; (3): 42-53.
  39. Torjesen I. Two doctors die from Ebola and lives of others under threat in West Africa. BMJ 2014; 349: g4895.
  40. Платонов А.Е., Малеев В.В., Санникова И.В., Пасечников В.Д., Карань Л.С., Платонова О.В., Куличенко А.Н. Крымская геморрагическая лихорадка в Евразии в XXI веке: вопросы патогенеза и лечения. Эпидемиол. и инфекц. болезни. Актуал. вопр. 2012; (6): 46-58.
  41. Reardon S. Ebola treatments caught in limbo. Nature 2014; 511 (7511): 520.
  42. Warren T.K., Wells J., Panchal R.G. et al. Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430. Nature 2014; 508(7496): 402-405.
  43. Wong G., Qiu X., Olinger G.G., Kobinger G.P. Postexposure therapy of filovirus infections. Trends Microbiol. 2014; 22(8): 456-463.
  44. Olinger G.G. Jr., Pettitt J., Kim D. et al. Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques. Proc. Natl. Acad. Sci. USA 2012; 109(44): 18030-18035.
  45. Rowe A.K., Bertolli J., Khan A.S. et al. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidemies a Kikwit. J. Infect. Dis. 1999; 179(Suppl 1): S28-S35.
  46. Kucharski A.J., Piot P. Containing Ebola virus infection in West Africa. Euro Surveill. 2014;19(36):pii=20899. Available online: http://www.eurosurveillance.org/ViewArticle. aspx?ArticleId=20899
  47. World Health Organization. Ebola situation in Liberia: non-conventional interventions needed. http://who.int/ mediacentre/news/ebola/8-september-2014/en/
  48. World Health Organization. Ebola Response Roadmap Situation Report 1. 29 August 2014. http://www.who.int/csr/ disease/ebola/situation-reports/29-august-2014.pdf?ua=1
  49. World Health Organization. Ebola Response Roadmap Situation Report 3. http://apps.who.int/iris/ bitstream/10665/133073/1/roadmapsitrep3_eng.pdf?ua=1
  50. World Health Organization. Virological analysis: no link between Ebola outbreaks in west Africa and Democratic Republic of Congo. http://who.int/mediacentre/news/ ebola/2 - september-2 014/en/#
  51. World Health Organization. Ebola virus disease - Democratic Republic of Congo. http://who.int/csr/ don/2014_09_10_ebola/en/
  52. Li Y.H., Chen S.P. Evolutionary history of Ebola virus. Epidemiol. Infect. 2014; 142(6): 1138-1145.
  53. Carroll S.A., Towner J.S., Sealy T.K. et al. Molecular evolution of viruses of the family Filoviridae based on 97 whole-genome sequences. J. Virol. 2013; 87(5): 2608-2616.
  54. Wittmann T.J., Biek R., Hassanin A. et al. Isolates of Zaire ebolavirus from wild apes reveal genetic lineage and recombinants. Proc. Natl. Acad. Sci. USA 2007; 104(43): 17123-17127.
  55. Gire S.K., Goba A., Andersen K.G. et al. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science 2014. http://www. sciencemag.org/content/early/2014/08/27/science.1259657. full.pdf
  56. Dudas G., Rambaut A. Phylogenetic analysis of Guinea 2014 EBOV Ebolavirus outbreak. PLoS Curr. 2014; 6. http://www. ncbi.nlm.nih.gov/pmc/articles/PMC4024086/
  57. Calvignac-Spencer S., Schulze J.M., Zickmann F., Renard B.Y. Clock rooting further demonstrates that Guinea 2014 EBOV is a member of the Zaire lineage. PLoS Curr. 2014; 6. http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC4073806/
  58. Vogel G. Genomes reveal start of Ebola outbreak. Science 2014; 345(6200): 989-990.
  59. Hayden E.C. Ebola virus mutating rapidly as it spreads. Outbreak likely originated with a single animal-to-human transmission. Nature 2014. http://www.nature.com/news/ ebola-virus-mutating-rapidly-as-it-spreads-1.15777
  60. Schoepp R.J., Rossi C.A., Khan S.H. et al. Undiagnosed acute viral febrile illnesses, Sierra Leone. Emerg. Infect. Dis. 2014; 20(7): 1176-1182.
  61. Chan M. Ebola virus disease in West Africa - No early end to the outbreak. N. Engl. J. Med. 2014 Aug 20. PubMed PMID: 25140856.
  62. World Health Organization. Unprecedented number of medical staff infected with Ebola. http://www.who.int/ mediacentre/news/ebola/25-august-2014/en/#
  63. Gulland A. Health ministers in west Africa hold crisis talks on Ebola virus. BMJ 2014; 348: g4478.
  64. World Health Organization. Ebola situation in Port Harcourt, Nigeria. http://who.int/mediacentre/news/ ebola/3-september-2014/en/#
  65. Gomes M.F.C., Pastore y Piontti A., Rossi L. et al. Assessing the international spreading risk associated with the 2014 West African Ebola outbreak. PLOS Currents Outbreaks 2014; Sep 2. Edition 1. doi: 10.1371/currents.outbreaks.cd81 8f63d40e24aef769dda7df9e0da5.
  66. Klompas M., Diekema D.J., Fishman N.O., Yokoe D.S. Ebola fever: reconciling Ebola planning with Ebola risk in U.S. hospitals. Ann. Intern. Med. 2014 Aug 21. PubMed PMID: 25141883.
  67. Centers for Disease Control and Prevention. Health Alert Network HAN 368: CDC Ebola Response Update #4. 2014. http://emergency.cdc.gov/han/han00368.asp
  68. Роспотребнадзор. О ситуации с лихорадкой Эбола. 2014. http://rospotrebnadzor.ru/region/210fz/index.php
  69. Роспотребнадзор. Рекомендации для медицинских работников по геморрагической лихорадке Эбола. 2014. http://rospotrebnadzor.ru/files/o-rekomendatsiyakh-po-likhoradke-ebola.pdf
  70. Dowell S.F., Mukunu R., Ksiazek T.G. et al. Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidemies a Kikwit. J. Infect. Dis. 1999; 179(Suppl 1): S87-S91.
  71. Francesconi P., Yoti Z., Declich S. et al. Ebola hemorrhagic fever transmission and risk factors of contacts, Uganda. Emerg. Infect. Dis. 2003; 9(11): 1430-1437.
  72. Bausch D.G., Towner J.S., Dowell S.F. et al. Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J. Infect. Dis. 2007; 196(Suppl 2): S142-S147.
  73. European Centre for Disease Prevention and Control. Outbreak of Ebola virus disease in West Africa. Fourth update, 3 September 2014. Stockholm: ECDC. 2014. http:// www.ecdc.europa.eu/en/publications/Publications/Ebola-virus-disease-west-africa-risk-assessment-27-08-2014.pdf
  74. Ijaz K., Kasowski E., Arthur R.R. et al. International Health Regulations--what gets measured gets done. Emerg. Infect. Dis. 2012; 18(7): 1054-1057.
  75. World Health Organization. Ebola Response Roadmap http://apps.who.int/iris/bitstream/10665/131596/1/ EbolaResponseRoadmap.pdf
  76. Nishiura H., Chowell G. Early transmission dynamics of Ebola virus disease (EVD), West Africa, March to August 2014. Euro Surveill. 2014; 19(36): pii=20894. Available online: http://www.eurosurveillance.org/ViewArticle. aspx?ArticleId=20894
  77. Fisman D., Khoo E., Tuite A. Early epidemic dynamics of the West African 2014 Ebola outbreak: estimates derived with a simple two-parameter model. PLOS Currents Outbreaks 2014; Sep 8. Edition 1. doi: 10.1371/currents.outbreaks.89c0 d3783f36958d96ebbae97348d571.
  78. Althaus C.L. Estimating the reproduction number of Ebola virus (EBOV) during the 2014 outbreak in West Africa. PLOS Currents Outbreaks 2014; Sep. 2. Edition 1. doi: 10.1371/currents.outbreaks.91afb5e0f279e7f29e705609525 5b288
  79. Gostin L.O., Lucey D., Phelan A. The Ebola epidemic: a global health emergency. JAMA 2014 Aug 11. PubMed PMID: 25111044.
  80. Hirschberg R., Ward L.A., Kilgore N. et al. Challenges, progress, and opportunities: proceedings of the filovirus medical countermeasures workshop. Viruses 2014; 6(7): 2673-2697.
  81. Marzi A., Feldmann H. Ebola virus vaccines: an overview of current approaches. Expert. Rev. Vaccines 2014; 13(4): 521-531.
  82. Galvani A.P., Ndeffo-Mbah M.L., Wenzel N., Childs J.E. Ebola vaccination: If not now, when? Ann. Intern. Med. 2014 Aug 21. PubMed PMID: 25141813.
  83. Goodman J.L. Studying «Secret Serums» - Toward Safe, Effective Ebola Treatments. N. Engl. J. Med. 2014 Aug 20. PubMed PMID: 25140857.
  84. Qiu X., Wong G., Audet J. et al. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature 2014; doi: 10.1038/nature13777. http://www.nature. com/nature/journal/vnfv/ncurrent/pdf/nature13777.pdf
  85. World Health Organization. Ethical considerations for use of unregistered interventions for Ebola virus disease Report of an advisory panel to WHO. http:// www.who.int/csr/resources/publications/ebola/ethical-considerations/en/
  86. World Health Organization. Statement on the WHO Consultation on potential Ebola therapies and vaccines. http://who.int/mediacentre/news/statements/2014/ebola-therapies-consultation/en/#
  87. Uebelhoer L.S., Albarino C.G., McMullan L.K. et al. High-throughput, luciferase-based reverse genetics systems for identifying inhibitors of Marburg and Ebola viruses. Antiviral Res. 2014; 106: 86-94.
  88. Enserink M. Infectious diseases. Debate erupts on ’repurposed’ drugs for Ebola. Science 2014; 345(6198): 718-719.
  89. Johansen L.M., Brannan J.M., Delos S.E. et al. FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection. Sci. Transl. Med. 2013; 5(190): 190ra79. doi: 10.1126/scitranslmed.3005471.
  90. Kass N. Ebola, ethics, and public health: what next? Ann. Intern. Med. 2014 Aug 19. PubMed PMID: 25133473.
  91. Arie S. Ebola: an opportunity for a clinical trial? BMJ 2014; 349: g4997.
  92. Интерфакс. Обама отправит в Африку три тысячи военнослужащих на борьбу с вирусом Эбола. http:// www.interfax.ru/world/3 96919
  93. UN News Centre. UN Security Council to hold emergency meeting on Ebola crisis. http://www.un.org/apps/news/ story.asp?NewsID=48715#.VBg9l_1xm1Z
  94. McNamara T., Platonov A., Elleman T., Gresham L. The human-animal interface and zoonotic threats: the Russian Federation approach. Biosecur. Bioterror. 2013; 11(3): 185-195.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Bionika Media, 2014

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>